CAMBRIDGE (CBS) – Moderna is one step closer to completing its coronavirus vaccine trial.

The Cambridge-based company said Thursday it has officially enrolled all 30,000 participants in the third phase of the trial, which involves two shots of the vaccination.

READ MORE: Mother Accused Of Putting Baby In Trash Can Charged With Attempted Murder

Right now, 25,654 (85-percent) of them have received the second dose.

READ MORE: Thieves Target Toyota Prius Catalytic Converters In Cambridge

Once everyone has the second vaccination, Moderna will take two months to assess the safety of it. If the benefits outweigh the risks, the company will then submit a request to the FDA to start emergency use of the vaccine. That would be given to frontline medical workers and other at-risk people first.

Moderna hopes the federal government could give approval for emergency use by the end of the year.

MORE NEWS: Mitt Romney Taken To Hospital For 'A Lot Of Stitches' After Fall In Boston